Oncology therapeutic spending growth 2013-2018 U.S. vs pharmerging
This statistic shows the annual growth of spending on oncology therapeutic medicines from 201 to 2018 in the United States compared to the so-called pharmerging markets. In 2013, there was a 9.7 percent growth in oncology therapeutic spending in the United States and an nine percent growth in therapeutic spending in the pharmerging markets.
